PMV Pharmaceuticals (PMVP) Net Equity Issued and Repurchased (2019 - 2026)
PMV Pharmaceuticals' Net Equity Issued and Repurchased came in at $143,000 for Q2 2026, up 38.8% from $103,000 a year earlier.
Powered by 
Analysis
PMV Pharmaceuticals (PMVP) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, PMV Pharmaceuticals reported Net Equity Issued and Repurchased of $535,000, up 87.7% year-over-year; for FY2025, it was $505,000, up 61.3% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -70.4% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $313,000 in FY2024 (-99.1%), $35.12 million in FY2023, $958,000 in FY2022 (-52.6%) and $2.02 million in FY2021 (-99.1%).
- The five-year range for quarterly Net Equity Issued and Repurchased is $6,000 (Q3 2022) to $33.1 million (Q3 2023).
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q2 2023 (growth of 629.7%), and the weakest in Q3 2022 (a decline of 98.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | PMV Pharmaceuticals | 89.28 Mn | -325.89 Mn | - | 143,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143,000.00 |
| Dec 31, 2025 | 392,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 172,000.00 |
| Jun 30, 2024 | 141,000.00 |
| Sep 30, 2023 | 33.10 Mn |
| Jun 30, 2023 | 2.01 Mn |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 276,000.00 |
| Mar 31, 2022 | 128,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 309,000.00 |
| Jun 30, 2021 | 1.26 Mn |
| Mar 31, 2021 | 162,000.00 |
| Dec 31, 2020 | -1.37 Mn |
| Dec 31, 2019 | 61.61 Mn |
API Access
PMV Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PMVP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PMVP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PMVP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();